Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Profit After Tax

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹707 Cr₹528 Cr₹562 Cr₹703 Cr₹419 Cr

What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?

The latest Profit After Tax ratio of EMCURE PHARMACEUTICALS is ₹707 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹707 Cr
Mar2024₹528 Cr
Mar2023₹562 Cr
Mar2022₹703 Cr
Mar2021₹419 Cr

How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?

Years Profit After Tax % Change
Mar2025 ₹707 Cr
34.10
Mar2024 ₹528 Cr
-6.10
Mar2023 ₹562 Cr
-20.03
Mar2022 ₹703 Cr
67.84
Mar2021 ₹419 Cr -

Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,128.9 Cr -0.4% -0.2% 44% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-0.4%

-0.2%

44%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses